The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma

被引:23
作者
Lee, IS
Kim, SH
Song, HG
Park, SH
机构
[1] Seoul Natl Univ, Coll Med, Dept Pathol, Inst Allergy & Clin Immunol,Chongno Gu, Seoul 110799, South Korea
[2] Konkuk Univ, Coll Sci, Dept Biol Sci, Seoul, South Korea
[3] Chungbuk Natl Univ, Coll Med, Dept Pathol, Cheongju, South Korea
关键词
H-RS cells; EBV-LMP1; CD99; NF-kappa B;
D O I
10.1007/BF02982639
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hodgkin's lymphoma (HL) is a lymphoid neoplasm with a low frequency of malignant tumor cells, known as Hodgkin and Reed-Sternberg (H-RS) cells, in a background of mixed cellular infiltrates. Despite extensive studies on H-RS cells, the molecular mechanisms of their growth and regulation have remained uncertain for a long period. Recently, constitutively activated nuclear factor-kappaB (NF-kappaB) was reported to be a unique and common characteristic of H-RS cells that prevents the cells from undergoing apoptosis. NF-kappaB triggers proliferation and provides a molecular basis for these cells' aberrant growth and cytokine gene expression. In HL pathogenesis associated with Epstein-Barr virus infection, the activation of NF-kappaB is induced by viral latent membrane protein 1 (LMP1). Coupled with recent insights into the molecular mechanisms of activation of NF-kappaB signaling in H-RS cells, this review discusses a linkage between LMP1 and HL via CD99, which has recently been reported to be down-regulated by LMP1 through the NF-kappaB signaling pathway. This down-regulation leads to the generation of cells with H-RS phenotypes related to the clinical and histologic characteristics of HL. (C)2003 The Japanese Society of Hematology.
引用
收藏
页码:330 / 335
页数:6
相关论文
共 82 条
[1]  
Annunziata CM, 2000, BLOOD, V96, P2841
[2]   Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adaptor proteins that regulates life and death [J].
Arch, RH ;
Gedrich, RW ;
Thompson, CB .
GENES & DEVELOPMENT, 1998, 12 (18) :2821-2830
[3]   Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells [J].
Bargou, RC ;
Emmerich, F ;
Krappmann, D ;
Bommert, K ;
Mapara, MY ;
Arnold, W ;
Royer, HD ;
Grinstein, E ;
Greiner, A ;
Scheidereit, C ;
Dörken, B .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :2961-2969
[4]   High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells [J].
Bargou, RC ;
Leng, C ;
Krappmann, D ;
Emmerich, F ;
Mapara, MY ;
Bommert, K ;
Royer, HD ;
Scheidereit, C ;
Dorken, B .
BLOOD, 1996, 87 (10) :4340-4347
[5]   Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain [J].
Baud, V ;
Liu, ZG ;
Bennett, B ;
Suzuki, N ;
Xia, Y ;
Karin, M .
GENES & DEVELOPMENT, 1999, 13 (10) :1297-1308
[6]  
BERBERICH I, 1994, J IMMUNOL, V153, P4357
[7]  
Bernard G, 1997, J IMMUNOL, V158, P2543
[8]   Localization of the major NF-kappa B-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs [J].
Brodeur, SR ;
Cheng, GH ;
Baltimore, D ;
ThorleyLawson, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) :19777-19784
[9]   Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα [J].
Cabannes, E ;
Khan, G ;
Aillet, F ;
Jarrett, RF ;
Hay, RT .
ONCOGENE, 1999, 18 (20) :3063-3070
[10]   EXPRESSION OF FUNCTIONAL CD30 ANTIGEN ON REED-STERNBERG CELLS AND HODGKINS-DISEASE CELL-LINES [J].
CARBONE, A ;
GLOGHINI, A ;
GATTEI, V ;
ALDINUCCI, D ;
DEGAN, M ;
DEPAOLI, P ;
ZAGONEL, V ;
PINTO, A .
BLOOD, 1995, 85 (03) :780-789